Edgestream Partners L.P. Has $2.65 Million Stock Position in Chemed Co. (NYSE:CHE)

Edgestream Partners L.P. lessened its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 51.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,007 shares of the company's stock after selling 5,404 shares during the quarter. Edgestream Partners L.P.'s holdings in Chemed were worth $2,653,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. CIBC Asset Management Inc raised its position in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after buying an additional 22 shares in the last quarter. EP Wealth Advisors LLC grew its stake in shares of Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company's stock worth $814,000 after acquiring an additional 25 shares during the last quarter. First Heartland Consultants Inc. raised its stake in shares of Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company's stock worth $305,000 after purchasing an additional 34 shares during the last quarter. Argonautica Private Wealth Management Inc. lifted its position in Chemed by 7.2% during the fourth quarter. Argonautica Private Wealth Management Inc. now owns 505 shares of the company's stock valued at $268,000 after purchasing an additional 34 shares during the period. Finally, SRS Capital Advisors Inc. increased its holdings in shares of Chemed by 39.2% during the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock valued at $72,000 after purchasing an additional 38 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Remove Ads

Chemed Stock Performance

Chemed stock traded up $0.79 during midday trading on Thursday, hitting $590.03. 69,256 shares of the company's stock were exchanged, compared to its average volume of 101,259. The firm's 50 day simple moving average is $557.78 and its 200 day simple moving average is $564.44. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62. The stock has a market cap of $8.64 billion, a price-to-earnings ratio of 29.81, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is 10.05%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Brian C. Judkins acquired 145 shares of the company's stock in a transaction dated Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.